Skip to search formSkip to main contentSkip to account menu

cefodizime

Known as: (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid 7(sup2)-(Z)-(O-methyloxime) 
A third-generation, aminothiazolyl cephalosporin for parenteral use. Cefodizime has broad-spectrum activity and is stable to most beta-lactamases.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
In this study, 100 febrile infants suffering from Urinary tract infection (rectal temperature > 38°C) who presented to the… 
2003
2003
This paper describes effects of some antibiotics on glutathione reductase in vitro. Glutathione reductase was purified from… 
2001
2001
Abstract.Objective: To describe an outbreak of acute renal failure (ARF) occurring in a group of patients undergoing open-heart… 
2001
2001
Cefodizime has modulating effects on the release of diverse cytokines. We determined the modulator activity of this antibiotic on… 
1988
1988
In vitro experiments suggest that cefodizime, a new cephalosporin, causes an increase in phagocytic capacity. We therefore… 
1986
1986
The 2-aminothiazolyl-4-yl-2-alkoxyiminoacetamido substituent-containing beta-lactam antibiotics (cephalosporins and monobactams… 
1986
1986
Indole-positive Klebsiella pneumoniae or K. oxytoca are usually resistant to penicillins as a result of the production of a… 
1986
1986
Minimal inhibitory concentrations (MICs) of cefodizime were evaluated by agar dilution for 746 bacterial strains isolated in two… 
1984
1984
Studies concerning the activity of cefodizime (HR 221), on certain aspects of the immune response, were conducted. It was found… 
1982
1982
The in vitro activity of cefodizime (HR-221), a new cephalosporin antibiotic, was compared with the activities of selected…